MarketersMEDIA Newsroom

How Creative Biolabs Reshapes Next-Generation RNA Drug Development with an "End-to-End Strategy"

Creative Biolabs optimizes the mRNA drug development model by integrating sequence design, RNA-protein interaction ...
Nasdaq

IDEAYA Announces Oral Presentation at the New Drugs on the Horizon Series at AACR 2025 for IDE275 (GSK959), a Phase 1 Werner Helicase Inhibitor

4 IDEAYA/GSK presentations of IDE275 (GSK959) and 4 additional presentations across IDE397/MAT2A, IDE161/PARG, PRMT5, and KAT6/7 programs at AACR 2025 IDE275 (GSK959) has demonstrated a potential best ...
The Conversation

Will AI revolutionize drug development? Researchers explain why it depends on how it’s used

Duxin Sun receives funding from the NIH, FDA, and pharmaceutical industries including Bristol-Myers Squibb, Celgene Corporation, Aurinia Pharmaceuticals, Abbvie, Nanomedicine Innovation Center.